A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects.

Trial Profile

A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 May 2016

At a glance

  • Drugs Evacetrapib (Primary) ; Atorvastatin
  • Indications Dyslipidaemias
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 02 Apr 2014 Results published in the American Journal of Cardiology.
    • 26 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top